EVIDITY CAPITAL LLC
MIAMI, FLORIDA

Canepa Healthcare, LLC (“Canepa Healthcare”) is a late-stage venture and growth capital firm specializing in medical technology. We focus on private companies with commercialized products that need growth capital to achieve profitability. Stage of company We seek out healthcare companies with products in the growth stage that have achieved regulatory clearance in the United States or Europe. We target those healthcare companies that can achieve rapid revenue growth over the next 3-5 years. We are interested companies needing at least $5M of new capital. We are flexible with respect to controlling versus minority roles but will only consider situations where there is an opportunity to add value through our active involvement. We focus on medical devices and diagnostics but do not restrict ourselves to specific sub-sectors. We prioritize products that fill significant clinical unmet needs in large addressable markets, are supported by high quality clinical data, have strong health economic value propositions, and are managed by world-class teams. is a privately held ophthalmic medical device company that develops and markets technologies for the improvement of near vision. The company’s proven, proprietary technology platforms use a small aperture – or pinhole – effect to allow only focused light rays to reach the retina and bring objects into clear focus. The result is unique, reliable and long-lasting performance. Using the small aperture concept, two products have been developed: the company’s flagship product – the KAMRA® corneal inlay – and the innovative IC-8® intraocular lens. Canepa Healthcare, LLC (“Canepa Healthcare”) is a late-stage venture and growth capital firm specializing in medical technology. We focus on private companies with commercialized products that need growth capital to achieve profitability. Stage of company We seek out healthcare companies with products in the growth stage that have achieved regulatory clearance in the United States or Europe. We target those healthcare companies that can achieve rapid revenue growth over the next 3-5 years. We are interested companies needing at least $5M of new capital. We are flexible with respect to controlling versus minority roles but will only consider situations where there is an opportunity to add value through our active involvement. We focus on medical devices and diagnostics but do not restrict ourselves to specific sub-sectors. We prioritize products that fill significant clinical unmet needs in large addressable markets, are supported by high quality clinical data, have strong health economic value propositions, and are managed by world-class teams. is a privately held ophthalmic medical device company that develops and markets technologies for the improvement of near vision. The company’s proven, proprietary technology platforms use a small aperture – or pinhole – effect to allow only focused light rays to reach the retina and bring objects into clear focus. The result is unique, reliable and long-lasting performance. Using the small aperture concept, two products have been developed: the company’s flagship product – the KAMRA® corneal inlay – and the innovative IC-8® intraocular lens. Canepa Healthcare, LLC (“Canepa Healthcare”) is a late-stage venture and growth capital firm specializing in medical technology. We focus on private companies with commercialized products that need growth capital to achieve profitability. Stage of company We seek out healthcare companies with products in the growth stage that have achieved regulatory clearance in the United States or Europe. We target those healthcare companies that can achieve rapid revenue growth over the next 3-5 years. We are interested companies needing at least $5M of new capital. We are flexible with respect to controlling versus minority roles but will only consider situations where there is an opportunity to add value through our active involvement. We focus on medical devices and diagnostics but do not restrict ourselves to specific sub-sectors. We prioritize products that fill significant clinical unmet needs in large addressable markets, are supported by high quality clinical data, have strong health economic value propositions, and are managed by world-class teams. is a privately held ophthalmic medical device company that develops and markets technologies for the improvement of near vision. The company’s proven, proprietary technology platforms use a small aperture – or pinhole – effect to allow only focused light rays to reach the retina and bring objects into clear focus. The result is unique, reliable and long-lasting performance. Using the small aperture concept, two products have been developed: the company’s flagship product – the KAMRA® corneal inlay – and the innovative IC-8® intraocular lens.